The impact of family history of hepatocellular carcinoma on its patients' survival

被引:0
|
作者
Wing Chiu Dai [1 ]
Sheung Tat Fan [1 ,2 ]
Tan To Cheung [1 ]
Kenneth SH Chok [1 ]
Albert CY Chan [1 ]
Simon HY Tsang [1 ]
Ronnie TP Poon [1 ,2 ]
Chung Mau Lo [1 ,2 ]
机构
[1] Department of Surgery , The University of Hong Kong, 102 Pokfulam Road, Hong Kong, China
[2] State Key Laboratory for Liver Research , The University of Hong Kong, 102 Pokfulam Road, Hong Kong, China
关键词
hepatocellular carcinoma; family history; resection; survival; risk factor;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND:Family history of hepatocellular carcinoma(HCC) has been identified as a risk factor for the development of the disease.The aim of this study is to evaluate the impact of such a history on HCC patients’ survival.METHODS:Data of all HCC patients(n=4532) managed at our center from 1989 to 2008 were prospectively collected.The patients were quizzed on their various characteristics including family HCC history.RESULTS:Totally 475(10.48%) patients had a family history of HCC.They presented the disease at a significantly earlier age(median 53 vs 59 years,P<0.0001) and at an earlier stage(the United Network for Organ Sharing staging system).They had significantly better liver function in terms of ChildPugh classification and serum albumin and bilirubin levels.Significantly more of them presented the disease without symptoms(44.0% vs 29.4%,P<0.0001).They also had significantly better overall survival under these specifications:patients in the whole study cohort,patients who had minor hepatectomy,patients with stage I disease,patients with stage II disease,and patients with stage III disease.CONCLUSIONS:Contrary to what is generally believed,we found in this study cohort that patients with a family history of HCC had better overall survival than those without such a history.We believe this was in part due to earlier diagnosis of the disease and better liver function in this group of patients.However,the effects of genetic factors on the risk of HCC cannot be overlooked and are yet to be identified.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 50 条
  • [31] The Impact of Social Determinants of Health on Survival and Disease Severity in Patients With Hepatocellular Carcinoma
    Farah, Bassem
    Manivannan, Ahila
    Harris, Kevin
    Salgia, Reena
    Michelle, Jesse
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S926 - S926
  • [32] Impact of statin on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib or lenvatinib
    Cho, Hyo Jung
    Han, Ji Eun
    Cheong, Jae Youn
    Kim, Soon Sun
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S572 - S572
  • [33] The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
    Branco, Fernanda
    Alencar, Regiane S. M.
    Volt, Fernanda
    Sartori, Giovana
    Dode, Andressa
    Kikuchi, Luciana
    Tani, Claudia M.
    Chagas, Aline L.
    Pfiffer, Tulio
    Hoff, Paulo
    Carrilho, Flair J.
    de Mattos, Angelo Alves
    [J]. ANNALS OF HEPATOLOGY, 2017, 16 (02) : 263 - 268
  • [34] Impact of tumor size and vascular invasion on survival of patients with small hepatocellular carcinoma
    Kikuchi, Luciana
    Vezozzo, Denise
    Chagas, Aline
    Mello, Evandro
    Farias, Alberto
    Pietrobon, Ricardo
    Carrilho, Flair
    Alves, Venancio
    [J]. VIRCHOWS ARCHIV, 2007, 451 (02) : 378 - 378
  • [35] IMPACT OF BRIDGING STRATEGIES ON SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA LISTED FOR LIVER TRANSPLANTATION
    Felsenreich, D. M.
    Gyoeri, G.
    Silberhumer, G.
    Wolf, F.
    Sieghart, W.
    Muehlbacher, F.
    Soliman, T.
    Berlakovich, G. A.
    [J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 15 - 16
  • [36] Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma
    Kobayashi, Kazufumi
    Ogasawara, Sadahisa
    Takahashi, Aya
    Seko, Yuya
    Unozawa, Hidemi
    Sato, Rui
    Watanabe, Shunji
    Moriguchi, Michihisa
    Morimoto, Naoki
    Tsuchiya, Satoshi
    Iwai, Kenji
    Inoue, Masanori
    Ogawa, Keita
    Ishino, Takamasa
    Iwanaga, Terunao
    Sakuma, Takafumi
    Fujita, Naoto
    Kanzaki, Hiroaki
    Koroki, Keisuke
    Nakamura, Masato
    Kanogawa, Naoya
    Kiyono, Soichiro
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Nakamoto, Shingo
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Nagashima, Kengo
    Kato, Jun
    Isoda, Norio
    Aramaki, Takeshi
    Itoh, Yoshito
    Kato, Naoya
    [J]. LIVER CANCER, 2021, : 48 - 60
  • [37] Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance
    Trevisani, Franco
    Magini, Giulia
    Santi, Valentina
    Morselli-Labate, Antonio Maria
    Cantarini, Maria Chiara
    Di Nolfo, Maria Anna
    Del Poggio, Paolo
    Benvegnu, Luisa
    Rapaccini, Gianludovico
    Farinati, Fabio
    Zoli, Marco
    Borzio, Franco
    Giannini, Edoardo Giovanni
    Caturelli, Eugenio
    Bernardi, Mauro
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (05): : 1022 - 1031
  • [38] Impact of surveillance on survival of patients with initial hepatocellular carcinoma: A study from Japan
    Toyoda, Hidenori
    Kumada, Takashi
    Kiriyama, Seiki
    Sone, Yasuhiro
    Tanikawa, Makoto
    Hisanaga, Yasuhiro
    Yamaguchi, Akihiro
    Isogai, Masatoshi
    Kaneoka, Yuji
    Washizu, Junji
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (09) : 1170 - 1176
  • [39] The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
    Han, Ji Eun
    Kim, Jisu
    Cheong, Jae Youn
    Kim, Soon Sun
    Lim, Sun Gyo
    Yang, Min Jae
    Noh, Choong-Kyun
    Lee, Gil Ho
    Eun, Jung Woo
    Park, Bumhee
    Cho, Hyo Jung
    [J]. CANCERS, 2024, 16 (02)
  • [40] IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Reggidori, N.
    Lani, L.
    Renzulli, M.
    Gramenzi, A.
    Iannone, G.
    Granito, A.
    Piscaglia, F.
    Golfieri, R.
    Trevisani, F.
    Biselli, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 : S151 - S151